NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Tanvex BioPharma Inc (TW: 6541)

 
6541 Technical Analysis
3
As on 31st Jul 2025 6541 STOCK Price closed @ 51.20 and we RECOMMEND Sell for LONG-TERM with Stoploss of 57.70 & Sell for SHORT-TERM with Stoploss of 55.59 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

6541STOCK Price

Open 51.20 Change Price %
High 51.80 1 Day -0.20 -0.39
Low 50.70 1 Week 0.70 1.39
Close 51.20 1 Month 0.70 1.39
Volume 410451 1 Year -13.70 -21.11
52 Week High 81.80 | 52 Week Low 36.95
 
TW Taiwan Most Active Stocks
2888 11.80 3.96%
1303 40.95 5.81%
1802 23.90 9.89%
1605 22.50 -1.75%
2317 178.00 3.79%
2887 16.35 -0.30%
2027 39.30 -2.84%
8033 95.60 0.31%
2408 44.55 -0.78%
1301 42.65 0.00%
 
TW Taiwan Top Gainers Stocks
6531 330.50 9.98%
2383 1105.00 9.95%
2383 1105.00 9.95%
8021 63.20 9.91%
8021 63.20 9.91%
1504 51.00 9.91%
1802 23.90 9.89%
1802 23.90 9.89%
1528 14.45 9.89%
1528 14.45 9.89%
 
TW Taiwan Top Losers Stocks
2393 69.30 -10.00%
2393 69.30 -10.00%
6289 1.35 -10.00%
6239 126.00 -9.35%
6288 21.15 -7.64%
6288 21.15 -7.64%
2801 18.50 -7.27%
2538 12.60 -7.01%
3501 54.80 -6.80%
4581 51.80 -6.67%
 
 
6541
Daily Charts
6541
Intraday Charts
Whats New @
Bazaartrend
6541
Free Analysis
 
6541 Important Levels Intraday
RESISTANCE53.32
RESISTANCE52.64
RESISTANCE52.22
RESISTANCE51.80
SUPPORT50.60
SUPPORT50.18
SUPPORT49.76
SUPPORT49.08
 
6541 Forecast August 2025
4th UP Forecast84.67
3rd UP Forecast73.94
2nd UP Forecast67.3
1st UP Forecast60.67
1st DOWN Forecast41.73
2nd DOWN Forecast35.1
3rd DOWN Forecast28.46
4th DOWN Forecast17.73
 
6541 Weekly Forecast
4th UP Forecast58.14
3rd UP Forecast55.91
2nd UP Forecast54.54
1st UP Forecast53.16
1st DOWN Forecast49.24
2nd DOWN Forecast47.86
3rd DOWN Forecast46.49
4th DOWN Forecast44.26
 
6541 Forecast2025
4th UP Forecast141.67
3rd UP Forecast112.66
2nd UP Forecast94.72
1st UP Forecast76.79
1st DOWN Forecast25.61
2nd DOWN Forecast7.68
3rd DOWN Forecast-10.26
4th DOWN Forecast-39.27
 
 
6541 Other Details
Segment EQ
Market Capital 17741051904.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
6541 Address
6541
 
6541 Latest News
 
Your Comments and Response on Tanvex BioPharma Inc
 
6541 Business Profile
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar and biologic products and drugs in Taiwan and the United States. The company's lead product candidate includes TX01 for the treatment of neutropenia. It also develops TX05, which has completed phase III clinical trial for the treatment of breast cancer; TX04 for the treatment of neutropenia; TX16 that has completed phase I clinical trial for the treatment of metastatic colorectal cancer; TX52, which is in pre-clinical trial; and other products. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands. Address: 802 West Bay Road, George Town, Cayman Islands, KY1-1205
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service